NEW YORK (GenomeWeb News) – The Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed Geneva Bioinformatics’ PhenyxServer protein identification and characterization software, GeneBio said today.
 
Under the agreement, Sloan-Kettering researcher Paul Tempst will use the Phenyx protein identification and characterization software in its Clinical Proteomic Technology Assessment for Cancer group.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.